Anzeige
Mehr »
Freitag, 03.04.2026 - Börsentäglich über 12.000 News
Strategisches Metall: China verknappt Germanium - und diese Aktie könnte davon erheblich profitieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16.03.Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility
16.03.Sentynl to License Investigational Molecule from PRG S&T for Progeria Treatment
16.03.Celltrion's Avtozma Available in Subcutaneous Formulation for US Patients
16.03.Sartorius Launches Eveo Cell Therapy Platform
16.03.Samsung Bioepis, Epis NexLab Partner with G2GBIO to Develop Novel Semaglutide Assets
16.03.Korsana Biosciences Taps Dr. Mark Vignola as CFO
13.03.Aptar Pharma, COVIRIX Medical Partner on Inhaled Antiviral Treatments
13.03.Verista Acquires Integral Solutions
13.03.Grail Inc. Announces CEO Transition
12.03.Lilly to Invest $3B to Expand GLP-1 Manufacturing Capacity in China
12.03.Valanx Biotech Secures €3 million in Latest Round of Financing
12.03.Halozyme Taps David Ramsay as Interim Chief Financial Officer
12.03.Almirall Opens New Offices in China to Advance Medical Dermatology Innovation
12.03.Lyocontract Breaks Ground on €50M Facility in Germany
12.03.Fujifilm Biotechnologies Appoints Chief Business Officer
12.03.BioDuro Appoints Scientific Advisors
12.03.SK pharmteco Earns CGMP Qualification for Facility in France
12.03.Trenchant BioSystems, Invetech Partner to Advance Trenchant's AutoCell Platform
12.03.Coriolis Pharma Opens New Site in North Carolina
11.03.Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada
11.03.Sandoz Creates Global Biosimilars Unit
11.03.iXCells Delivers 500+ Characterized iPSC Lines for Global Biotechnology Company
11.03.Bespak Expands Manufacturing Capacity to Support Chiesi CMI Program
11.03.GelMEDIX, Catalent Partner to Advance iPSC-Derived Cell Therapies
10.03.Abselion Launches U.S. Subsidiary in Massachusetts